Humoral response to the BBIBP-CorV vaccine over time in healthcare 2 workers with or without exposure to SARS-CoV-2

BADANO MARÍA NOEL; SABBIONE FLORENCIA; KEITELMAN IRENE; PERESON MATIAS ; ALOISI NATALIA; COLADO ANA; RAMOS MARIA VICTORIA; ORTIZ WILCZYÑSKI JUAN MANUEL; POZNER ROBERTO GABRIEL; CASTILLO LUIS; WIGDOROVITZ GEORGINA; DE ELIZALDE DE BRACCO, MARÍA M.; FINK SUSANA; CHUIT ROBERTO; BARÉ PATRICIA

Seminario; Seminarios IMEX; 2021

IMEX

SARS-CoV-2-specific humoral response was analyzed over time in healthcare workers with or without SARS-CoV-2 exposure, who received the BBIBP-CorV (Sinopharm) vaccine in Argentina. Seroconversion rates in unexposed subjects after the first and second doses were 40% and 100%, respectively, showing an increase in antibody concentrations from dose 1 to dose 2 (p